Skip to main content
SP5007,711.76-0.25%DOW53,559.99-0.02%NASDAQ26,402.42-0.52%BTC$77,728.00-3.40%ETH$2,441.16-2.91%GOLD$4,504.10-3.43%OIL$83.44-0.11%
Smart Investors Daily
Sign InSign Up Free
NO

NYSE · NOVTU

Novanta Inc. Tangible Equity Units

Technology · Hardware, Equipment & Parts

$61.64

Down-$1.21 (-1.96%)

Updated Aug 30, 2026, 6:46 PM

SID Score

4.8/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
2B
P/E ratio
81.9
Dividend yield
3.79%
52-week range
$50.70 – $76.95
Volume
2.32K
Avg. volume
492.9K

Price performance

NOVTU price history

1M range · 19 trading sessions · Daily adjusted prices

NOVTU closed at $61.64 after 19 trading sessions, down 1.93% for the selected period.

Last close
$61.64
Period change
-1.93%
Period low
$59.66
Period high
$69.96
Daily close
View OHLC price history
NOVTU OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Aug 27, 2026$60.85$61.64$60.83$61.642.32K
Aug 26, 2026$60.35$61.53$60.35$61.52879
Aug 25, 2026$60.00$60.00$59.83$59.911.89K
Aug 24, 2026$60.76$60.76$59.66$59.665.7K
Aug 21, 2026$61.90$62.26$61.37$62.261.73K
Aug 20, 2026$63.98$63.98$61.44$62.0552.36K
Aug 19, 2026$65.00$65.10$61.93$61.93109.82K
Aug 18, 2026$76.89$76.95$65.64$65.645K
Aug 17, 2026$75.00$75.00$68.66$69.5655.13K
Aug 14, 2026$69.20$69.20$69.07$69.081.52K
Aug 13, 2026$75.00$75.00$67.52$69.833.24K
Aug 12, 2026$69.00$69.96$69.00$69.961.59K
Aug 11, 2026$75.26$75.26$68.55$68.959.98K
Aug 10, 2026$67.92$68.58$67.68$68.426.3K
Aug 7, 2026$75.59$75.59$69.11$69.1138.76K
Aug 6, 2026$69.55$72.29$67.90$67.9059.39K
Aug 5, 2026$65.51$65.76$64.40$64.404.06K
Aug 4, 2026$64.75$66.82$64.75$66.8259.14K
Aug 3, 2026$62.43$62.88$62.02$62.8516.15K

Latest NOVTU news

The latest Smart Investors Daily articles mentioning NOVTU.

Stock researchCompany · Overview

NOVTU research

Overview

Company profile and research snapshot.

Company profile

Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
—
Implied upside
—
Analysts
10
NOVTU recent ratings
DateFirmRatingTarget
May 13, 2026BairdOutperform—
Mar 30, 2026BairdOutperform—
Aug 11, 2025BairdNeutral—
Mar 3, 2025BairdNeutral—
Nov 6, 2024BairdNeutral—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Aug 14, 2026

5 Revealing Analyst Questions From Novanta’s Q2 Earnings Call

Novanta's second quarter was marked by broad-based organic growth across all business units and a favorable response from the market. Management attributed the strong results to both an acceleration in new product revenue—up more than 50% year-over-year—and operational improvements, including factory consolidations. CEO Matthijs Glastra highlighted that all business units grew organically and pointed to increased customer demand in precision robotics, AI-driven manufacturing, and minimally invas

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By